Analysis To Follow
For whatever reason, the biotech (LABD) short is not performing as expected.
However, the oil market looks like it may have topped out.
Exit LABD and re-position short oil sector via inverse fund DUG (absolutely not advice, not a recommendation) 🙂
Charts by StockCharts
Note: Posts on this site are for education purposes only. They provide one firm’s insight on the markets. Not investment advice. See additional disclaimer here.
The Danger Point®, trade mark: No. 6,505,279